Maynard Um
-
-
-
-
-
-
-
Marker Therapeutics (MRKR) Misses Q3 EPS by 12c
-
-
-
-
-
-
-
Marker Therapeutics (MRKR) Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
-
-
-
418,491 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

